Assenagon Asset Management
PRTK

Assenagon Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Assenagon Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$935K Buy
2022
Q4 		$245K Sell
2022
Q3 		$551K Buy
2022
Q2 		$181K Buy